Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Change in Inventory (2016 - 2019)

Aptevo Therapeutics (APVO) has disclosed Change in Inventory for 5 consecutive years, with -$1.3 million as the latest value for Q4 2019.

  • Quarterly Change in Inventory changed N/A to -$1.3 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2019, changed N/A year-over-year, with the annual reading at $4.4 million for FY2019, 475.17% up from the prior year.
  • Change in Inventory hit -$1.3 million in Q4 2019 for Aptevo Therapeutics, down from $515000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.9 million in Q3 2018 to a low of -$8.6 million in Q3 2016.
  • Historically, Change in Inventory has averaged -$226000.0 across 5 years, with a median of $257000.0 in 2018.
  • Biggest five-year swings in Change in Inventory: plummeted 827.55% in 2016 and later surged 1453.6% in 2018.
  • Year by year, Change in Inventory stood at -$1.4 million in 2015, then crashed by 253.51% to -$4.9 million in 2016, then skyrocketed by 95.76% to -$209000.0 in 2017, then soared by 1507.18% to $2.9 million in 2018, then tumbled by 145.66% to -$1.3 million in 2019.
  • Business Quant data shows Change in Inventory for APVO at -$1.3 million in Q4 2019, $515000.0 in Q3 2019, and $2.6 million in Q2 2019.